Singstrong: Singing for Better Lung Health

NCT04266951 | Completed

• 1 other identifier: NF1
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Chronic Obstructive Pulmonary Disease (COPD) is a pervasive, insidious condition associated with catastrophic socioeconomic, healthcare and personal implications. This proposal outlines how a group singing intervention, led by clinical personnel and a community singing leader, can address these challenges. Built upon existing ties between the Principal Investigator (PI) and local COPD support group, this project is co-designed by patients and clinicians. Modelled on similar interventions internationally, this project is pioneering in Ireland. Outputs will include a participant-led symposium and three community COPD choirs, in addition to a number of academic publications. This project is funded by the Irish Research Council (IRC) "New Foundations" scheme.

Conditions

Respiratory Disease; COPD

Outcome Measures

Primary Outcomes (3)

• Patient anxiety and depression

  Hospital Anxiety and Depression Scale (HADS). This questionnaire is widely used to measure anxiety and depression in a general medical population of patients. The questionnaire features seven questions for anxiety and seven for depression of which can be answered within 2 - 5 minutes. Each item is scored from 0-3 with a higher score indicating a greater presence of either anxiety or depression. Maximal (worst) score for either factor is 21.

  8 weeks

• Functional capacity

  Six minute walk test (6MWT). The 6MWT is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity. This is measured in metres with levels of oxygen saturation and heart rate pre and post the test also recorded.

  8 weeks

• Disease impact

  COPD Assessment test (CAT). The CAT is a questionnaire for people with COPD. It is designed to measure the impact of COPD on a person's life, and how this changes over time. This is a patient-completed questionnaire assessing all aspects of the impact of COPD (cough, sputum, breathlessness, chest tightness, confidence, activity, sleep and energy levels) There are 8 questions on a 1 to 5 point scale. A higher score indicates more disease impact. Max score is 40.

  8 weeks

Secondary Outcomes (2)

• Lung function

  8 weeks

• Qualitative evaluation of intervention

  8 weeks

Study Arms (1)

Group singing and breathing control training

OTHER

Behavioral: Singstrong:

Interventions

Singstrong: BEHAVIORAL

Group singing and breathing control training

Group singing and breathing control training

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participants must have an existing diagnosis of COPD according to recognised diagnostic criteria, must be clinically stable, and not have suffered an exacerbation in the 2 weeks prior to testing.
• All participants must be at least 18 years of age. There is no upper age limit.
• Participants may be male or female.
• They must have a good command of written and spoken English.

You may not qualify if:

• Lack of a clinical diagnosis of COPD
• Presence of physical of psychological co-morbidities precluding participation in either testing or intervention.

Sponsors & Collaborators

• University of Limerick: lead
• Irish Research Council: collaborator

Study Sites (1)

University of Limerick

Limerick, Ireland

Location

MeSH Terms

Conditions

Respiration Disorders; Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Roisin Cahalan, PhD

  University of Limerick

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Pilot study: Pre and post intervention with a single patient cohort.

Study Record Dates

• First Submitted: June 14, 2019
• First Posted: February 12, 2020
• Study Start: April 1, 2019
• Primary Completion: March 31, 2020
• Study Completion: April 30, 2020
• Last Updated: January 31, 2025

Record last verified: 2025-01

Data Sharing

• IPD Sharing: Will not share

Locations

IE (1)